<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.carenet.com/news/clear/journal/62779</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-05-08</news:publication_date>
      <news:title>糖尿病患者の心血管リスク軽減のための先手必勝手段：PCSK9阻害薬による早期介入？（解説：島田俊夫氏）</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/62794</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-05-08</news:publication_date>
      <news:title>医療者向けChatGPT登場！米国在住の医師が特別レポート</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/journal/carenet/62792</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-05-08</news:publication_date>
      <news:title>60歳以上の甲状腺機能低下症、レボチロキシン中止は可能か／JAMA</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/journal/carenet/62791</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-05-08</news:publication_date>
      <news:title>HER2変異陽性NSCLCの1次治療、ゾンゲルチニブが奏効率76％・PFS14.4ヵ月を達成（Beamion LUNG-1）／NEJM</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/62744</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-05-08</news:publication_date>
      <news:title>アルツハイマー病に対する4つの第2世代抗精神病薬の死亡リスク比較</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
</urlset>
